← Back to headlines
Evolus outlines 2026 revenue guidance of $327M–$337M while expanding international presence and product portfolio
Evolus, a medical aesthetics company, has outlined its revenue guidance for 2026, projecting $327M–$337M, alongside plans for expanding its international presence and product portfolio.
4 Mar, 07:42 — 4 Mar, 07:42
ℹOnly 1 source covers this story
